Abstract
Purpose: To evaluate the dosimetric feasibility of using low energy sources (Cs‐131, I‐125, Pd‐103) in the multi‐lumen device for partial breast brachytherapy. The sources are placed into the device for multiple days until the desired dose is achieved, then withdrawn with the device. This outpatient procedure only requires two visits, one for source placement and another for device withdrawal. Method: A 10‐1 SAVI device was fully expanded, CT‐scanned and imported into VariSeed. Cavity, PTV (cavity + 1cm margin) and PTV_eval (PTV − cavity) were created. The same type and activity of seeds were added into the multi‐lumen device to cover the PTV_eval and seed activity was adjusted to achieve a nominal dose (50Gy in one half‐life of source). Different seed types and distributions were tested. Oncentra Brachy and IPSA optimization was used to generate a HDR plan for comparison. Dosimetric parameters (D90, V100, V150, and V200 of PTV_eval) and skin dose were compared. Results: D90, V100, V150, and V200 of PTV_eval of HDR plan are 107%, 97%, 52cc, and 24cc. The most comparable LDR plan is from a non‐uniform distributed 90 3.2U Cs‐131 source, which gives 102%, 92%, 52cc, and 26cc. Skin dose is lower than the HDR plan by ∼10% of the prescription dose from 0.5 ∼ 5 cm away from the PTV edge. With the comparable coverage, I‐125 gives slightly higher V150 and V200 (56cc and 30cc, respectively), while Pd‐103 gives much higher V150 and V200 (66cc and 46cc respectively). Conclusion: Cs‐131 is the best choice among the 3 commercially available low energy sources. It can provide adequate target coverage and similar dose homogeneity compared to HDR dosimetry in reasonable days (10 days). The faster dose fall‐off of the low energy sources give it advantage of less dose to the surrounding healthy tissues including skin, heart, and lung.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.